Astellas, Japan's AIST Join To Develop Neglected Tropical Disease Drugs
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma said it has reached an agreement with Japan's National Institute of Advanced Industrial Science and Technology for joint development of treatments for protozoan parasite-based tropical diseases.